HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

We evaluated the safety and efficacy of high-dose, posttransplantation cyclophosphamide (Cy) to prevent graft rejection and graft-versus-host disease (GVHD) after outpatient nonmyeloablative conditioning and T cell-replete bone marrow transplantation from partially HLA-mismatched (haploidentical) re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Luznik, Leo, O’Donnell, Paul V., Symons, Heather J., Chen, Allen R., Leffell, M. Susan, Zahurak, Marianna, Gooley, Ted A., Piantadosi, Steve, Kaup, Michele, Ambinder, Richard F., Huff, Carol Ann, Matsui, William, Bolaños-Meade, Javier, Borrello, Ivan, Powell, Jonathan D., Harrington, Elizabeth, Warnock, Sandy, Flowers, Mary, Brodsky, Robert A., Sandmaier, Brenda M., Storb, Rainer F., Jones, Richard J., Fuchs, Ephraim J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2633246/
https://ncbi.nlm.nih.gov/pubmed/18489989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.03.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados